(1aR,12bS)-8-cyclohexyl-11-fluoro-N-((1-methylcyclopropyl)sulfonyl)-1a-((3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl)-1,1a,2,2b-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-5-carboxamide for use in treating HCV

• 收藏
• 分享

专利权人:

发明人:

申请号：

EP14165031.7

公开号：

EP2792360A1

申请日:

2014.04.16

申请国别(地区):

EP

年份:

2014

代理人:

摘要：

The invention relates to an administration unit comprising a compound of formulaand/or pharmaceutically acceptable salts thereof, and to a packaging comprising the administration unit according to the invention.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/